Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Disease Exacerbation
100%
Gene Locus
100%
Cell Line
75%
Neoplasm
50%
Gene Mutation
50%
Phosphotransferase
50%
Cyclin Dependent Kinase Inhibitor 2A
50%
Phosphatidylinositol
50%
Tumor Cell
25%
B Cell
25%
Cell Signaling Pathway
25%
Phosphoinositide 3-Kinase
25%
Enzyme Active Site
25%
Neck
25%
Protein P53
25%
Squamous Cell Carcinoma
25%
P16
25%
Karyotype
25%
Clinical Pathway
25%
Keyphrases
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Disease Progression
100%
Genetic Pathways
100%
Genetic Modification
50%
Gene Locus
50%
Tumor
33%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
33%
Phosphatidylinositol 3
33%
Molecular Events
33%
Tumor Cells
16%
Signaling Pathway
16%
Phosphoinositide 3-kinase (PI3K)
16%
Head-and-neck
16%
PIK3CA
16%
Gene Targeting
16%
Catalytic Subunit
16%
B Cell Lines
16%
Squamous Cell Carcinoma of Head
16%
CDKN2B
16%
P53 Pathway
16%
Prognostic Groups
16%
Genetic Loci
16%
Recurrent or Metastatic
16%
PIK3CA Gene
16%
HNSCC Cell Lines
16%
Biochemistry, Genetics and Molecular Biology
Gene Locus
100%
Gene Mutation
50%
Phosphotransferase
50%
Kinase
50%
Cyclin Dependent Kinase Inhibitor 2A
50%
Phosphatidylinositol
50%
B Cell
25%
P53
25%
Karyotype
25%
Phosphoinositide 3-Kinase
25%
Enzyme Active Site
25%
P16
25%
Cytogenetics
25%
CDKN2B
25%